T1	Phenotype	120 147	UGT1A1 deficiency screening
T2	Chemical	214 231	irinorecan -based
T3	Chemical	272 297	irinotecan -based therapy
T4	Disease	310 329	colorectal cancer .
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	influences	Arg1:T1	Arg2:T4
R4	influences	Arg1:T2	Arg2:T1
R5	treats	Arg1:T2	Arg2:T3
R6	treats	Arg1:T2	Arg2:T4
R7	influences	Arg1:T3	Arg2:T2
R8	treats	Arg1:T3	Arg2:T4
R9	isAssociatedWith	Arg1:T4	Arg2:T1
